NeuroOne Medical Technologies Co. (NASDAQ:NMTC) Short Interest Up 15.8% in August

NeuroOne Medical Technologies Co. (NASDAQ:NMTC) was the target of a significant increase in short interest in August. As of August 31st, there was short interest totalling 130,200 shares, an increase of 15.8% from the August 15th total of 112,400 shares. Based on an average daily volume of 81,300 shares, the days-to-cover ratio is currently 1.6 days. Approximately 0.5% of the shares of the company are short sold.

NeuroOne Medical Technologies Stock Performance

Shares of NASDAQ:NMTC traded up $0.12 during trading on Tuesday, reaching $0.93. The company had a trading volume of 66,401 shares, compared to its average volume of 136,112. The firm’s fifty day moving average is $0.81 and its 200 day moving average is $0.97. The firm has a market capitalization of $25.89 million, a PE ratio of -1.55 and a beta of 0.70. NeuroOne Medical Technologies has a twelve month low of $0.60 and a twelve month high of $2.00.

NeuroOne Medical Technologies (NASDAQ:NMTC) last released its earnings results on Wednesday, August 14th. The company reported ($0.10) earnings per share for the quarter. NeuroOne Medical Technologies had a negative return on equity of 276.12% and a negative net margin of 308.51%. The firm had revenue of $0.83 million during the quarter.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.